<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04890730</url>
  </required_header>
  <id_info>
    <org_study_id>NEFC-2020-222</org_study_id>
    <nct_id>NCT04890730</nct_id>
  </id_info>
  <brief_title>Non-invasive Method for Predicting the Presence of Gastroesophageal Varices in Patients With Cirrhosis-a Prospective, Multicenter Trial</brief_title>
  <official_title>Southern Medical University of Nanfang Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanfang Hospital of Southern Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanfang Hospital of Southern Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroesophageal varices are a complication of portal hypertension in cirrhosis.Endoscopy is&#xD;
      an unsatisfactory screening test.In this prospective clinical study,we will enroll patients&#xD;
      with cirrhosis of various causes, all of whom undergo laboratory tests, elastography, and&#xD;
      serum proteomic differential protein testing, including liver elastography (LSM) and spleen&#xD;
      elastography (SSM). Baveno VI or expanded BavenoVI criteria are validated by comparing&#xD;
      patients' LSM and PLT. LSM, SSM, serum differential protein, platelet count, and EGD data to&#xD;
      evaluate the clinical value of SSM and differential proteins in excluding cirrhosis with&#xD;
      varices. At the same time, a new predictive model of variceal varices will be established to&#xD;
      evaluate the diagnostic value of SSM and differential protein for esophagogastric varices,&#xD;
      and a non-invasive method for reliably predicting and evaluating cirrhosis with esophageal&#xD;
      varices will be found. And each patient will be followed up every 6 months to 1 year, and the&#xD;
      outcome event will be recorded.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Gastroesophageal varices are a complication of portal hypertension in cirrhosis.Endoscopy is&#xD;
      invasive method as an unsatisfactory screening test.In this prospective clinical study, we&#xD;
      will enroll patients with cirrhosis of various causes, all of patients whom undergo&#xD;
      laboratory tests, elastography, and serum proteomic differential protein testing, including&#xD;
      LSM and SSM. Baveno VI or expanded BavenoVI criteria are validated by comparing patients' LSM&#xD;
      and PLT. LSM,SSM, serum differential protein, platelet count, and EGD data to evaluate the&#xD;
      clinical value of SSM and differential proteins in excluding cirrhosis with varices. At the&#xD;
      same time, based on SSM and serum differential protein, a new predictive model of variceal&#xD;
      varices will be established to evaluate the diagnostic value of SSM and differential protein&#xD;
      for esophagogastric varices, and a non-invasive method for reliably predicting and evaluating&#xD;
      cirrhosis with esophageal varices will be found. And each patient will be followed up every 6&#xD;
      months to 1 year, and the outcome event will be recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of high-risk esophageal varices</measure>
    <time_frame>4 years</time_frame>
    <description>Incidence of high-risk esophageal varices</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of hemorrhagic events</measure>
    <time_frame>4 years</time_frame>
    <description>Incidence of hemorrhagic events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Clinical decompensation events and deaths</measure>
    <time_frame>4 years</time_frame>
    <description>Incidence of Clinical decompensation events and deaths</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">992</enrollment>
  <condition>Gastroesophageal Varices; Decompensation Event</condition>
  <arm_group>
    <arm_group_label>Southern Medical University of Nanfang Hospital</arm_group_label>
    <description>Southern Medical University of Nanfang Hospital</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tongji Hospital Affiliated to Tongji University</arm_group_label>
    <description>Tongji Hospital Affiliated to Tongji University</description>
  </arm_group>
  <arm_group>
    <arm_group_label>The Second Affiliated Hospital Of Nanchang University</arm_group_label>
    <description>The Second Affiliated Hospital Of Nanchang University</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Esophagogastroduodenoscopies</intervention_name>
    <description>Each enrolled patient needs to undergo Esophagogastroduodenoscopies and elastography</description>
    <arm_group_label>Southern Medical University of Nanfang Hospital</arm_group_label>
    <arm_group_label>The Second Affiliated Hospital Of Nanchang University</arm_group_label>
    <arm_group_label>Tongji Hospital Affiliated to Tongji University</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Take 10ml blood sample for each patient&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who come to the center to see a doctor who meet the enrollment criteria and agree&#xD;
        to participate in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. The age ranged from 18 to 80 years. 2. Clinical or pathological diagnosis of&#xD;
             cirrhosis; 3. Electronic gastroscopy is planned; 4. To agree and sign the informed&#xD;
             consent;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  1. Hepatocellular carcinoma or other malignant tumors have been or are currently&#xD;
             diagnosed; 2. Orthotopic liver transplantation patients; 3. Patients who have&#xD;
             undergone transjugular intrahepatic portosystemic shunt (TIPS),or previous surgical&#xD;
             shunt; 4. Pregnant women; 5. Neurological or psychiatric disorders;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Jinjun Chen, PHd</last_name>
    <phone>8618588531001</phone>
    <email>chjj@smu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haiyu Wang</last_name>
    <phone>15602203979</phone>
    <email>375612668@qq.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University</name>
      <address>
        <city>Guangzhou</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinjun Chen, PHD</last_name>
      <phone>86-18588531001</phone>
      <email>chjj@smu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 10, 2021</study_first_submitted>
  <study_first_submitted_qc>May 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 16, 2021</last_update_submitted>
  <last_update_submitted_qc>May 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal and Gastric Varices</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

